查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1563836

全球女性健康检查市场

Women's Health Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球女性健康检查市场规模将达439亿美元

预计2023年全球女性健康检查市场规模为297亿美元，预计2030年将达439亿美元，2023-2030年分析期间复合年增长率为5.7%。乳癌检测应用是本报告分析的细分市场之一，预计复合年增长率为 7.3%，到分析期结束时将达到 113 亿美元。分析期间，传染病检查应用领域的复合年增长率预计为4.7%。

美国市场预计79亿美元，中国预计复合年增长率9.9%

预计 2023 年美国女性健康诊断市场规模将达 79 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到106亿美元，2023-2030年分析期间复合年增长率为9.9%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.2% 和 5.8%。在欧洲，德国的复合年增长率预计为 2.8%。

全球女性健康诊断市场—主要趋势与驱动因素总结

为什么女性健康检查成为医疗保健领域的焦点？

由于人们对主要影响女性的疾病（如乳癌、子宫颈癌、骨质疏鬆症和生殖疾病）的早期发现、预防和管理的认识和关注不断提高，女性用健康检查成为医疗保健领域的焦点。这些诊断包括广泛的测试和筛检方法，用于监测和管理不同生命阶段的女性健康，包括诊断影像、分子就地检验和基于实验室的检测。随着个人化医疗、预防医学和以患者为中心的方法日益受到重视，女性健康检查对于改善世界各地女性的健康结果和生活品质变得至关重要。

哪些技术创新将彻底改变女性健康检查？

分子诊断、诊断影像和就地检验的技术进步正在彻底改变女性的健康筛检。次世代定序（NGS）、液态切片和伴同性诊断的发展使得更准确、非侵入性地检测基因突变、癌症和其他健康状况成为可能，从而导致更有针对性的治疗和个人化治疗计划。 3D乳房X光摄影、超音波和磁振造影(MRI) 等影像技术的创新使乳房组织的可视化更加准确和详细，从而增强了乳癌的早期检测和诊断。此外，人工智慧主导的分析、数位病理学和远端医疗的整合正在提高女性健康检查的可及性、效率和准确性，使检查更加方便患者且更具成本效益。

女性健康诊断市场面临哪些挑战与机会？

女性健康诊断市场由多种因素推动，包括先进诊断测试的高成本、低收入地区获得优质医疗保健的机会有限，以及需要提高对面临挑战的女性健康问题的认识和教育。此外，诊断测试的监管和报销环境复杂且耗时。然而，这些挑战也带来了巨大的成长和创新机会。癌症、心血管疾病和骨质疏鬆症等慢性病的盛行率不断上升，推动了对早期检测和预防性诊断的需求。个人化医疗、远端医疗和家庭检测的兴起为诊断製造商创造了新的成长机会，这些製造商提供创新、方便且价格实惠的解决方案。此外，人们对妇女健康倡议、政府措施和公共卫生宣传活动的兴趣日益浓厚，对全面全面的妇女健康检查的需求也随之增加。

是什么推动了女性健康检查市场的成长？

女性健康诊断市场的成长是由女性慢性病和文明病的盛行率不断上升、对早期检测和个人化医疗的需求不断增加以及分子​​诊断、诊断成像和人工智慧主导分析的技术进步所推动的。随着医疗保健提供者和患者寻求改善女性的健康结果和生活质量，对提供早期检测、非侵入性检测和标靶治疗的全面、准确的诊断解决方案的需求将极大地推动市场需求。次世代定序、数位病理学、人工智慧主导的诊断和远端医疗等技术创新正在提高女性健康检查的能力和可及性，使其对医疗保健专业人员和患者都更具吸引力。随着相关人员寻求针对女性健康的先进、综合诊断解决方案，预防性护理的扩展、远端医疗和家庭检测的增长以及对女性健康宣传和意识提升的日益关注正在推动市场成长。

受访企业范例（41家知名企业）

  • Alere, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Quest Diagnostics, Inc.
  • Siemens AG

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP15688

Global Women's Health Diagnostics Market to Reach US$43.9 Billion by 2030

The global market for Women's Health Diagnostics estimated at US$29.7 Billion in the year 2023, is expected to reach US$43.9 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Breast Cancer Testing Application, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the Infectious Disease Testing Application segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.9 Billion While China is Forecast to Grow at 9.9% CAGR

The Women's Health Diagnostics market in the U.S. is estimated at US$7.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$10.6 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Women’s Health Diagnostics Market - Key Trends & Drivers Summarized

Why Is Women’s Health Diagnostics Gaining Prominence in Healthcare?

Women’s health diagnostics is gaining prominence in healthcare due to the growing awareness and focus on early detection, prevention, and management of diseases that predominantly affect women, such as breast cancer, cervical cancer, osteoporosis, and reproductive health disorders. These diagnostics encompass a wide range of tests and screening methods, including imaging, molecular diagnostics, point-of-care testing, and lab-based assays, to monitor and manage women's health across different life stages. With the increasing emphasis on personalized medicine, preventive care, and patient-centric approaches, women’s health diagnostics are becoming essential for improving health outcomes and quality of life for women worldwide.

What Technological Innovations Are Transforming Women’s Health Diagnostics?

Technological advancements in molecular diagnostics, imaging, and point-of-care testing are significantly transforming women’s health diagnostics. The development of next-generation sequencing (NGS), liquid biopsy, and companion diagnostics is enabling more precise and non-invasive detection of genetic mutations, cancers, and other health conditions, leading to better-targeted therapies and personalized treatment plans. Innovations in imaging technologies, such as 3D mammography, ultrasound, and magnetic resonance imaging (MRI), are providing more accurate and detailed visualization of breast tissues, enhancing early detection and diagnosis of breast cancer. Additionally, the integration of AI-driven analytics, digital pathology, and telemedicine is improving the accessibility, efficiency, and accuracy of women’s health diagnostics, making them more patient-friendly and cost-effective.

What Are the Challenges and Opportunities in the Women’s Health Diagnostics Market?

The women’s health diagnostics market faces several challenges, including the high cost of advanced diagnostic tests, limited access to quality healthcare in low-income regions, and the need for increased awareness and education about women’s health issues. The regulatory and reimbursement landscape for diagnostic tests can also be complex and time-consuming. However, these challenges present significant opportunities for growth and innovation. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and osteoporosis, is driving the demand for early detection and preventive diagnostics. The rise of personalized medicine, telehealth, and home-based testing is creating new growth opportunities for diagnostic manufacturers to offer innovative, accessible, and affordable solutions. Moreover, the growing focus on women’s health advocacy, government initiatives, and public health campaigns is driving the need for comprehensive and integrated women’s health diagnostics.

What Is Driving the Growth of the Women’s Health Diagnostics Market?

The growth in the Women’s Health Diagnostics market is driven by several factors, including the increasing prevalence of chronic and lifestyle-related diseases among women, rising demand for early detection and personalized medicine, and technological advancements in molecular diagnostics, imaging, and AI-driven analytics. The need for comprehensive and accurate diagnostic solutions that offer early detection, non-invasive testing, and targeted therapies is significantly boosting market demand as healthcare providers and patients seek to improve health outcomes and quality of life for women. Technological innovations such as next-generation sequencing, digital pathology, AI-driven diagnostics, and telemedicine are enhancing the capabilities and accessibility of women’s health diagnostics, making them more attractive to both healthcare professionals and patients. The expansion of preventive care, the growth of telehealth and home-based testing, and the increasing focus on women’s health advocacy and awareness are also driving market growth as stakeholders seek advanced and integrated diagnostic solutions for women’s health.

Select Competitors (Total 41 Featured) -

  • Alere, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Quest Diagnostics, Inc.
  • Siemens AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Women's Health Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases and Growing Awareness for Early Detection in Women
    • Increasing Demand for Point-of-Care and Home-Based Diagnostic Solutions
    • Advancements in Molecular Diagnostics and Next-Generation Sequencing for Women's Health
    • Growing Focus on Personalized Medicine and Companion Diagnostics for Targeted Therapies
    • Impact of Digital Health and Telemedicine on Women's Health Diagnostics Accessibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Women's Health Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Breast Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Infectious Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cervical Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Osteoporosis Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Prenatal Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Prenatal Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Prenatal Genetic Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pregnancy & Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pregnancy & Fertility Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Diagnostic & Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • JAPAN
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • CHINA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • EUROPE
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • FRANCE
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • GERMANY
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • INDIA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • AFRICA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030

IV. COMPETITION